Changes of blood pressure and hemodynamic parameters after oral magnesium supplementation in patients with essential arterial hypertensio
Not Applicable
- Conditions
- Essential (primary) hypertension.High blood pressure, Hypertension (arterial)(benign)(essential)(malignant)(primary)(systemic)
- Registration Number
- IRCT2017081535716N1
- Lead Sponsor
- -
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
age 24-65; essential arterial hypertention; unchanged antihipertensive therapy for at least one month;
Exclusion criteria: renal diseases, gastrointestinal diseases, diabetes mellitus, diseases od adrenal, thyroid and parathyroid glands, angina pectoris, congestive heart failure, aortic coarctation, food and drugs allergy, pregnancy, lactation, myocardial infarction, coronary revascularisation, transitory ischemic attack, oral intake of magnesium supplements in the last one month
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method